Choose your Region

Are you sure you want to proceed?

You will be leaving the Cook Medical website that you were viewing and going to a Cook Medical website for another region or country. Not all products are approved in all regulatory jurisdictions. The product information on these websites is intended only for licensed physicians and healthcare professionals.

February 24th, 2015

Cook Medical launches SialoCath™ Salivary Duct Catheter

Bloomington, Ind. – Physicians who treat obstructive salivary gland disorders now have the option of a specialized catheter designed to irrigate the salivary duct and flush out stone fragments. Cook Medical’s SialoCath™ Salivary Duct Catheter is a flexible, soft-tipped, single-lumen catheter indicated for use in the submandibular or parotid glands. It can be inserted into a salivary duct over a wire guide or through a Kolenda Introducer Sheath.

“SialoCath provides physicians with a minimally invasive tool for treating patients during in-office or surgical sialendoscopy procedures,” said Thomas Cherry, global leader of Cook’s Otolaryngology/Head & Neck Surgery (OHNS) clinical division. “The development of this catheter is part of Cook’s long-standing commitment to creating innovative devices that fulfill clinical needs.”

SialoCath is one device in a growing suite of Cook Medical sialendoscopy access and interventional tools that are now available to physicians in the U.S., Canada and select European markets. For more information about SialoCath and other OHNS products, visit and follow us on Twitter @CookOHNS.

About Cook Medical
Since 1963 Cook Medical has worked closely with physicians to develop technologies that eliminate the need for open surgery. Today we are combining medical devices, biologic materials and cellular therapies to help the world’s healthcare systems deliver better outcomes more efficiently. We have always remained family owned so that we have the freedom to focus on what we care about: patients, our employees and our communities. Find out more at, and for the latest news, follow us on Twitter, Facebook and LinkedIn.